
BellaSeno’s Resorbable Breast Implants
Medical deviceAbout
BellaSeno's resorbable breast implants are designed using polycaprolactone (PCL), a biocompatible polymer that gradually resorbs over time. These implants are part of a novel approach to breast reconstruction and augmentation, aiming to replace traditional silicone implants with a more natural solution. The PCL scaffolds are produced using 3D printing technology, allowing for customization to fit individual patient needs. The process involves combining the scaffold with autologous fat tissue, which is obtained through liposuction, promoting natural tissue regeneration as the scaffold resorbs. Clinical trials have shown promising results, with no major complications reported and significant improvements in patient quality of life. The scaffolds have demonstrated reliable volume replacement capabilities, and patients have reported enhanced comfort compared to traditional implants. BellaSeno's technology offers a potential alternative to permanent implants, reducing risks associated with silicone, such as capsular contracture and implant rupture. This approach could transform the breast implant market by providing a safer, more natural option for both aesthetic and reconstructive surgeries.